Recruiting

Cholesterol Management

Sponsor:

University of Texas at Austin

Code:

NCT07464574

Conditions

ASCVD Management

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pharmacy Intern Counseling

Study Details

Brief summary:

  • The purpose of the study is to improve care for patients with high cholesterol.
  • If you choose to join the study, you will be asked to answer a phone call from study personnel. They will help you coordinate follow up appointments, review your medications and lab with you, and answer any questions you have about your medications. You will also continue to be seen by a clinical pharmacy team member. Your cholesterol medications may change to better lower your cholesterol. We will collect information about your visits, medicines, and cholesterol levels for 6 months.
  • If you choose not to participate, you will receive the same information and treatment at your next scheduled visit. You will receive the same care regardless of choosing to participate in the study.
  • Participation might involve a very low risk of some loss of privacy. There is low risk that someone outside the research study could see information about you.
  • A possible benefit is lower cholesterol.
  • Taking part in this research study is your choice. You do not have to participate, and you can stop at any time without any penalty.

Conditions

ASCVD Management

Study ID

NCT07464574

Start date

Jan 16, 2026

Status verified date

Mar, 2026

Completion date

May 1, 2027

Anticipated

Primary completion date

Dec 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult patients (>18 years) who have seen a CommUnityCare provider in the previous 12 months at time of enrollment, who have a documented history of clinical ASCVD, and are not achieving LDL targets (either <55 or <70 mg/dL based on risk factors)

Exclusion Criteria:

  • Patients will be excluded if they do not have a clearly documented history clinical ASCVD, are already achieving LDL targets (either <55 or <70 mg/dL based on risk factors), having cholesterol managed by outside provider (e.g. outside cardiologist/lipid specialist), current pregnancy, have not seen a CUC provider in the previous 12 months, or otherwise do not qualify for clinical pharmacy intervention

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

Enrolled Patients

Adult patients (>18 years) who have seen a CommUnityCare provider in the previous 12 months at time of enrollment, who have a documented history of clinical ASCVD, and are not achieving LDL targets (either <55 or <70 mg/dL based on risk factors)

Interventions

Pharmacy Intern Counseling

The research intervention consists of outreach conducted by a Texas-licensed pharmacist intern under the supervision of CuC-employed pharmacists. Eligible patients will be contacted by a student pharmacist after the clinical pharmacists' appointment (described above in the standard of care) using CuC's RingCentral telehealth system. During this outreach, student pharmacists will review current lipid-lowering therapies, medication adherence, education about lipid-lowering therapies, and review of labs. Student pharmacists will not make independent prescribing or care decisions. All prescribing authority and therapeutic adjustments remain under the direction of CuC-employed pharmacists in accordance with the standard operating procedures. Patients will be informed about the research project during the outreach call or during a separate call dedicated to recruitment prior to the outreach call. Informed consent will be sent and obtained via either the EHR messaging system (MyChart) or text

Primary outcome measure

  • Percentage of patients at LDL target [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Locations

CommUnityCare Health Centers

Recruiting

Austin, Texas, United States, 78741

Contacts

More Information

Sponsor

University of Texas at Austin

Last update posted

Mar 11, 2026

Last verified

Mar, 2026

Keywords

  • non-statin

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Texas at Austin on 2026-03-11.